CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical company dedicated to ushering in…
Summer Appreciation Sales Offers 12% Off All Products NEW YORK, Aug. 15, 2025 /PRNewswire/ -- BestQool , a pioneer manufacturer…
Our software solution will provide states with modern, flexible technology to implement Medicaid work requirements while achieving human-centered outcomes and…
Group Health Life and Benefits Brokers can leverage PerfectQuote's Digital Quoting Platform to receive firm, underwritten level funded quotes directly…
SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- Citizen Health, a patient-powered platform transforming rare disease care, announced today it has…
LOUISVILLE, Ky., Aug. 14, 2025 /PRNewswire/ -- RAAPID, a leading provider of AI-powered risk adjustment solutions, today announced its participation…
SEATTLE, Aug. 14, 2025 /PRNewswire/ -- To the Invictus Foundation, CSX's support represents the best of good corporate citizenship," states Peter…
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty…
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical…
Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic malformations completed enrollment, exceeding enrollment…